The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages

Detalles Bibliográficos
Autores principales: Arora, Prerna, Zhang, Lu, Nehlmeier, Inga, Kempf, Amy, Cossmann, Anne, Dopfer-Jablonka, Alexandra, Schulz, Sebastian R, Jäck, Hans-Martin, Behrens, Georg M N, Pöhlmann, Stefan, Hoffmann, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621698/
https://www.ncbi.nlm.nih.gov/pubmed/36327999
http://dx.doi.org/10.1016/S1473-3099(22)00693-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621698/
https://www.ncbi.nlm.nih.gov/pubmed/36327999
http://dx.doi.org/10.1016/S1473-3099(22)00693-4

Ejemplares similares